BofA Securities Reiterates Buy Rating on Medtronic, Inc. (MDT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
Goldman Sachs Reiterates Sell Rating on Medtronic, Inc. (MDT)
July 11, 2025 12:26 PM EDTGoldman Sachs analyst David Roman reiterated a Sell rating and $78.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "On Thursday, July 10th, the Centers for Medicare and Medicaid Services (CMS) released a proposed Decision Memo to cover Renal Denervation (RDN) -- either radiofrequency (Medtronic) or ultrasound-based (Recor Medical, a subsidiary of... More
Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT)
July 11, 2025 8:22 AM EDTRaymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).
The analyst comments "CMS released its proposed National Coverage Determination (NCD) for Renal Denervation (RDN) last night (here). An NCD provides necessary scope around clinical eligibility for reimbursement purposes. The timeline was expected (on/before July 11). This document triggers another 30-day comment period, culminating with a final NCD expected to be published on/around October 8, 2025. Punchline: We believe the document reads well with no unexpected restrictions. CMSs inclusion threshold of 140 mmHg ambulatory blood pressure (which we believe equates... More
